Development of an Adaptive Treatment for Weight Loss in People With Prediabetes
- Conditions
- PreDiabetesObesity
- Interventions
- Behavioral: Reduced Carbohydrate DietBehavioral: High Carbohydrate Diet
- Registration Number
- NCT04745572
- Lead Sponsor
- University of Alabama at Birmingham
- Brief Summary
This 16-week study will use an experimental approach called the Sequential Multiple Assignment Randomized Trial to help determine which combination and sequence of weight loss program features are most effective in people who are at risk for type 2 diabetes. Participants in the study will be initially randomized to consume either a high or reduced carbohydrate diet. After 4 weeks, participants will be identified as Responders (greater than or equal to 2.5% weight loss) or Non-Responders (less than 2.5% weight loss). Responders will continue with their initial randomized group for the remainder of the trial. Non-responders will be re-randomized to 2nd stage interventions of either including additional exercise counseling and training or beginning a time restricted eating protocol for the remainder of the trial.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 90
- 18-75 years of age
- BMI of 27 kg/m2 or greater
- at risk for developing type 2 diabetes (prediabetes)
- Pregnant, planning to become pregnant, or breastfeeding
- uncontrolled hypo or hyperthyroidism
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SEQUENTIAL
- Arm && Interventions
Group Intervention Description Reduced Carbohydrate Diet Reduced Carbohydrate Diet Enrollment in a group-based behavioral weight loss intervention based on the Diabetes Prevention Program curriculum with reduced carbohydrate diet plan. High Carbohydrate Diet High Carbohydrate Diet Enrollment in a group-based behavioral weight loss intervention based on the Diabetes Prevention Program curriculum with high carbohydrate diet plan.
- Primary Outcome Measures
Name Time Method Changes in body weight week 16 visit Measured on digital scale at final visit.
- Secondary Outcome Measures
Name Time Method Change in glucose week 16 visit Serum glucose will be measured in a fasted state.
Change in hemoglobin A1c week 16 visit A1c is a measure of average glucose over the previous 3 months.
Change in insulin week 16 visit Serum insulin will be measured in a fasted state.
Changes in QUICKI index week 16 visit Predictor of insulin resistance that will be calculated from glucose and insulin measures
Trial Locations
- Locations (1)
UAB Highlands Family and Community Medicine Clinic
🇺🇸Birmingham, Alabama, United States